Alas I was long MSB from pre- and COVID lows, but unusually, did not exercise discipline in selling and out near highs (who'd have thought all four trials/applications would get so royally cocked up?)! Went a little early recently on PNV at $1.20 average, but the Chairman buying a big signal and the thing is so low because of fund selling ahead of likely ASX200 removal in June IMO (same with MSB March).
Point is its been a horrible year for Aussie small cap bio-techs all over. Even mkt darling IMU punished, $0.16 from $0.62 highs today.
This is a trading thread. And whilst bio-tech declines with general US mkt declines may persist, OCC has shown itself time and time again to be a buy between announcements and a sell on them, for those trading, that is.
We are due in May/June:
Final Remplir results for all patients in the nerve regeneration study (and lets hope some decent FDA progression news)
Final data from the OrthoATI Phase 2a study (and lets hope some JNJ [DePuy Synthes] forward interest)
Full recruitment for ATI vs Surgery RCT (and lets hope an initial data release).
Alas I was long MSB from pre- and COVID lows, but unusually, did...
-
- There are more pages in this discussion • 819 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23269 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |